The Riverside Company, a global private equity firm focused on the smaller end of the middle market, is pleased to announce the successful listing of its portfolio company Mintra Holding AS, the leadi...
The Riverside Company, a global private equity firm focused on the smaller end of the middle market, has invested in INVIVO Communications (INVIVO), a Toronto-based digital scientific communications p...
The Riverside Company’s private credit fund, Riverside Credit Solutions (RCS), has provided Black Rock Coffee Holdings (Black Rock) a senior secured lending facility for its roll-up of franchise sto...
The Riverside Company, a global private equity firm focused on the smaller end of the middle market, has invested in Life Sciences Training Institute (LSTI), a provider of on-demand and customized com...
The Riverside Company, a global private equity firm focused on the smaller end of the middle market, has invested in Germany-based Evint, a workforce management software provider. The investment is an...
The Riverside Company has invested in HealthTech BioActives, a Spanish manufacturer of active pharmaceutical ingredients (APIs), excipients, flavorings and sweeteners for the pharmaceutical, nutraceut...
The Riverside Company has signed a definitive agreement to sell its investment in Euromed Botanicals S.A. (Euromed) to Dermapharm Holding SE. Barcelona-based Euromed provides standardized herbal extra...
El fondo The Riverside Company prepara la venta de Euromed, la firma catalana especializada en la producción de extractos de principios activos de plantas y hierbas naturales para las industrias farm...
The Riverside Company has added Probelte Biotecnología S.A. (ProbelteBio) to its Euromed platform. Based in Murcia, Spain, ProbelteBio develops and manufactures ingredients for natural dietary supple...
Riverside has extensive experience in its Healthcare Specialization, having completed 85 deals in the space, including supplement and pharmaceutical companies